Prostate cancer: open trials in South Korea

62 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Seoul National University Hospital-Oncology ( Site 1401), Seoul · Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1404), Seoul · Samsung Medical Center ( Site 1405), Seoul · Asan Medical Center-Oncology ( Site 1402), Songpagu
Registry updated 2026-11-05
NCT06334120
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-11-05
NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Yonsei University - Severance Hospital - Colorectal Cancer Clinic, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea - St. Vincent's Hospital - Lung Cancer Center, Suwon
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Asan Medical Center, Seoul
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT07423117
A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy
Trial Treatment · Phase 1 · IntoCell, Inc
Asan Medical Center, Seoul · Severance hospital, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-11-04
NCT05800665
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Genentech, Inc.
Asan Medical Center - PPDS, Seoul · Severance Hospital Yonsei University Health System - PPDS, Seoul · Samsung Medical Center - PPDS, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Chungnam National University Hospital, Daejeon · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, HwasunGun · Samsung Medical Center, Seoul · The Catholic University of Korea Seoul St Marys Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
National Cancer Center, Goyang-si · The Catholic University of Korea Seoul St Marys Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul
Registry updated 2026-11-03
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Kyungpook National University Chilgok Hospital, Daegu · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun · Chungnam national university hospital, Junggu · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Ulsan University Hospital ( Site 0793), Donggu · Chonnam National University Hwasun Hospital ( Site 0794), Hwasun Gun · The Catholic University of Korea St. Mary s Hospital ( Site 0795), Seocho-gu · Severance Hospital Yonsei University Health System ( Site 0790), Seoul · Samsung Medical Center ( Site 0792), Seoul · Asan Medical Center ( Site 0791), Songpagu
Registry updated 2026-10-30
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Inje University Haeundae Paik Hospital, Busan · Korea University Anam Hospital, Seoul · Ajou University School of Medicine & Graduate School of Medicine, Suwon
Registry updated 2026-10-30
NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Seoul
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Kyungpook National University Chilgok Hospital, Daegu · National Cancer Center, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul
Registry updated 2026-10-26
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-23
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Seoul
Registry updated 2026-10-22
NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Pfizer
Kyungpook National University Chilgok Hospital, Daegu · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Kyungpook National University Chilgok Hospital-Urology ( Site 1252), Buk-gu · National Cancer Center-Center for Urologic Cancer ( Site 1254), Goyang-si · Pusan National University Yangsan Hospital ( Site 1256), Pusan · Seoul National University Bundang Hospital-Urology ( Site 1253), Seongnam · The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 1255), Seoul · Seoul National University Hospital-Urology ( Site 1251), Seoul
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-20
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Goyang-si · Seoul
Registry updated 2026-10-19
NCT07871435
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Trial Treatment · Phase 1/2 · GI Innovation, Inc.
Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Korea University Anam Hospital, Seoul · Ewha Womans University Mokdong Hospital, Seoul · Yonsei University Health System, Severance Hospital, Seoul
Registry updated 2026-10-19
NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial Treatment · Phase 1 · Pfizer
Chungnam National University Hospital, Daejeon · Seoul National University Bundang Hospital, Seongnam · Ewha Womans University Mokdong Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-15
NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-15
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Daegu · Goyang-si · Seoul
Registry updated 2026-10-15
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Busan · Daegu · Goyang-si · Seongnam-si · Seoul
Registry updated 2026-10-14

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error